(Q37808218)

23 August 2017

title

Immunotherapy of MHC class I-deficient tumors (English)

1 reference

23 August 2017

1 reference

Milan Reiniš

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1577-1589

1 reference

Immune therapy for cancer

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Viral strategies of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Epigenetic control of the immune escape mechanisms in malignant carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Histone deacetylase regulation of immune gene expression in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Epigenetic regulation of immune escape genes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

The innate immune response to tumors and its role in the induction of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I-deficient and -proficient HPV16-associated tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Antigen presented by tumors in vivo determines the nature of CD8+ T-cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

NKG2D ligands in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli beta-glucuronidase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.128

21 January 2018

Identifiers

DOI

10.2217/FON.10.128

1 reference

23 August 2017

1 reference